In CHB infection, KLRG1+ NK cells, the number of which is increased in PB and liver samples, can inhibit liver fibrosis by enhancing the apoptosis of activated hepatic stellate cells through the upregulation of expression of tumor necrosis factor-related apoptosis-inducing ligands. The gene discussed is KLRG1; the disease is Hepatic fibrosis.